F.D.A. Affirms Safety of Breast Implants -

August 31, 2011. The New York Times. Dr. Diana Zuckerman, president of National Research Center for Women & Families, told an FDA advisory panel that Allergan and Mentor did a poor job studying patients that got silicone implants.

Most women with silicone breast implants need more surgery -

MSNBC. June 22, 2011. Diana Zuckerman, president of the National Research Center for Women & Families, says the studies the FDA used to say silicone implants are safe are incomplete. In addition, Zuckerman claims women need to understand that when they get breast implants they may need removal or replacements for the rest of their lives.

Experts say medical device review system flawed -

The Miami Herald. July 29, 2011. NRC President Diana Zuckerman expresses concern over the vast majority of medical devices being cleared through the 510(k) process—a process which has been described as “flawed” by Institute of Medicine panelists in a new report.

The Effects of a Controversial Cancer Drug -

Washington Post, Letters to the Editor, August 22, 2010. If a breast cancer patient takes Avastin, it will not improve her chances of living longer, but her quality of life is more likely to be harmed because of the debilitating conditions linked to the drug.

Recalled Devices Mostly Untested, New Study Says -

New York Times. February 14, 2011. Dr. Diana Zuckerman and Paul Brown of the National Research Center for Women & Families publish study that finds that a vast majority of recalled medical devices that are intended to save lives were not tested on humans or animals.

Recalled medical devices undergo little testing, study finds -

Milwaukee Journal Sentinel. February 14, 2011. Dr. Diana Zuckerman and Paul Brown of the National Research Center for Women & Families publish a study that finds that the vast majority of recalled medical devices were approved by the FDA using lax standards.